Malaria Prevalence Around Maferinyah, Guinea
Cross-Sectional Survey of Plasmodium and Other Parasites in Pregnant Women and Infants Around Maferinyah, Guinea
2 other identifiers
observational
3,392
1 country
1
Brief Summary
Background: Many women in Sub-Saharan Africa get malaria while they are pregnant. Plasmodium falciparum is a parasite that can cause malaria. Placental malaria (PM) caused by P. falciparum can cause anemia or death in first-time mothers. In infants, it can cause low birth weight, premature birth, or other problems. Some women don t show any signs of having PM. This makes it harder to know if they might have it. Researchers want to learn how much the seasons affect the number of women and infants who get PM as well as the severity of the disease. To do this, they are going to test women and babies who visit a health center in Guinea. Objective: To learn the seasonal burden of P. falciparum infection in pregnant women and otherwise healthy infants. Eligibility: Pregnant women ages 18 years and older (or emancipated minors) and infants ages 6-12 months. Design: Participants will include women and infants who visit the health center in Maf(SqrRoot)(Registered Trademark)rinyah, Guinea, for routine care. They can take part only once per pregnancy. For screening, mothers will talk about their medical history. They will talk about their past pregnancies and their current pregnancy. They will answer questions about where they live and what they do to keep from getting malaria. Babies will be screened with their medical history and demographic information. Participants will also give a blood sample. Adults will have a finger stick. Children will have a heel stick. Or they will have blood taken from a vein. Participation will last for 1 visit to the health center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2019
CompletedFirst Posted
Study publicly available on registry
September 26, 2019
CompletedStudy Start
First participant enrolled
July 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedNovember 14, 2023
November 1, 2023
3.3 years
September 25, 2019
November 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Estimate of the seasonal burden of Plasmodium falciparum infection among pregnant women and otherwise healthy infants
seasonal burden of Plasmodium falciparum infection
3 years
Secondary Outcomes (1)
Estimate of the frequency of parasitemia due to non-falciparum malaria
3 years
Study Arms (2)
Older Infants
Infants age 6-12 months presenting for routine healthy visits
Pregnant Women
Women 18 years and older (and emancipated minors) presenting for routine antenatal visits
Eligibility Criteria
Pregnant women 18 years of age and older (including emancipated minors) and 6-12 month old infants presenting for routine visits at Maf(SqrRoot)(Registered Trademark)rinyah Health Centers
You may qualify if:
- For pregnant women, a study participant must satisfy the following criteria to be enrolled in this study:
- Pregnant women greater than or equal to 18 years of age (or emancipated minors) reporting for routine antenatal care at the health center without acute illness
- The study participant understands the study and gives informed consent for participation
- Willingness to share a positive test result for malaria or helminths with the health center in Maf(SqrRoot)(Registered Trademark)rinyah so treatment can be initiated if necessary
- Willingness to allow stored laboratory specimens to be used for future research
- For children, a study participant must satisfy the following criteria to be enrolled in this study:
- Children 6-12 months of age at time of visit presenting for routine care at the health center without acute illness
- The parent or guardian understands the study and gives informed consent for participation of their child
- Willingness of parent/guardian to share a positive test result for malaria or helminths with the health center in Maferinyah so treatment can be initiated if necessary
- Willingness of parent/guardian to allow stored laboratory specimens to be used for future research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maferinyah Rural Health Training and Research Center
Maferinyah, Guinea
Related Publications (2)
Kwan JL, Seitz AE, Fried M, Lee KL, Metenou S, Morrison R, Kabyemela E, Nutman TB, Prevots DR, Duffy PE. Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania. PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006345. doi: 10.1371/journal.pntd.0006345. eCollection 2018 Mar.
PMID: 29579050BACKGROUNDRogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018 Apr;18(4):e107-e118. doi: 10.1016/S1473-3099(18)30066-5. Epub 2018 Jan 31.
PMID: 29396010BACKGROUND
Biospecimen
Finger prick/heel stick samples and peripheral blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick E Duffy, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2019
First Posted
September 26, 2019
Study Start
July 13, 2020
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
November 14, 2023
Record last verified: 2023-11